Clinical outcomes of COVID-19 in patients with chronic diseases

Yasar Sertbas1, Ebru Elci Solak2, Selma Dagci3

  • 1Department of Internal Medicine, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkiye.

Northern Clinics of Istanbul
|September 18, 2023
PubMed

Insights

COVID-19 patients with chronic diseases (CDs) face higher risks of intensive care unit (ICU) admission and mortality. Specific conditions like hypertension, diabetes, and cancer independently increase ICU risk, while cardiovascular disease, chronic kidney disease, and psychiatric disorders elevate mortality risk.

Area of Science:

  • Medical research
  • Infectious diseases
  • Public health

Background:

  • COVID-19 significantly impacts global health, with chronic diseases (CDs) posing a major concern.
  • Understanding the interplay between COVID-19 and pre-existing conditions is crucial for patient management.

Purpose of the Study:

  • To evaluate the clinical outcomes of patients with chronic diseases (CDs) who are infected with COVID-19.
  • To identify specific chronic conditions that increase the risk of severe outcomes in COVID-19 patients.

Main Methods:

  • Retrospective study including 1,516 patients with diagnosed COVID-19 and pre-existing chronic diseases.
  • Chronic diseases evaluated included cardiovascular diseases, diabetes mellitus (DM), hyperlipidemia, asthma, chronic obstructive pulmonary diseases, rheumatological diseases, malignancy, cerebrovascular disease, and chronic kidney diseases (CKD).
  • Statistical analysis was performed to determine risk factors for hospitalization, intensive care unit (ICU) admission, and mortality.

Main Results:

  • 68.9% of COVID-19 patients had at least one chronic disease; women had a higher prevalence (73.8%) than men (64.8%).
  • Patients with CDs were significantly older, had longer hospital stays, were 5.49 times more likely to require ICU admission, and had a 2.52 times higher mortality rate.
  • Independent risk factors for ICU admission included hypertension (HT) (OR: 2.39), DM (OR: 3.64), and cancer (OR: 2.75).
  • Independent risk factors for mortality included cardiovascular diseases (OR: 2.27), CKD (OR: 3.69), and psychiatric disorders (OR: 2.18).

Conclusions:

  • COVID-19 patients with chronic diseases require more cautious clinical follow-up.
  • Patients with HT, DM, and cancer are at higher risk for ICU admission.
  • Patients with cerebrovascular disease, CKD, and psychiatric disorders face an increased risk of mortality.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
333
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K